Abbott Labs (ABT) PT Lowered to $110; Bernstein: 'Good entry point, or value trap?'
Tweet Send to a Friend
Bernstein SocGen Group analyst Lee Hambright lowered the price target on Abbott Labs (NYSE: ABT) to $110.00 (from $125.00) while ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
